|
Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of …
Stockhouse NEW YORK, NY–(Marketwired – October 29, 2014) – Relmada Therapeutics, Inc. (OTCQB: RLMD), a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline, received a healthy injection of more than $15 million … |
